v3.26.1
Equity
 6 Months Ended
May 31, 2026
Equity [Abstract]  
EQUITY STOCKHOLDERS' EQUITY:
Share Repurchase Program
In March 2024, the Board of Directors authorized a $2.0 billion share repurchase program (the "share repurchase program") pursuant to which the Company may repurchase its outstanding common stock from time to time in the open market or through privately negotiated transactions, including pursuant to one or more Rule 10b5-1 trading plans adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The share repurchase program does not have an expiration date.
As of May 31, 2026, the Company had $1.0 billion available for future repurchases of its common stock under the share repurchase program.
The Company's treasury stock activity during the six months ended May 31, 2026, including common share repurchases, is summarized as follows:
SharesWeighted-average price per share
Treasury stock balance as of November 30, 2025
18,912 $107.79 
Shares of treasury stock repurchased under share repurchase program (1)
1,095 175.39 
Shares of treasury stock repurchased for tax withholdings on equity awards39 171.92 
Shares of treasury stock reissued for employee benefit plans(373)108.59 
Treasury stock balance as of May 31, 2026
19,673 $111.73 
_________________________
(1) Weighted-average price per share excludes broker's commissions and excise taxes. "Repurchases of common stock" in the Consolidated Statements of Cash Flows for the six months ended May 31, 2026 and 2025 excludes amounts related to excise tax that when accrued are included in "Other current liabilities" and "Treasury stock" on the Consolidated Balance Sheets. Excise taxes paid are classified as operating activities in the Consolidated Statements of Cash Flows.
Dividends
On June 25, 2026, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.48 per common share payable on July 31, 2026 to stockholders of record as of the close of business on July 17, 2026. Dividends are subject to continued capital availability and the declaration by the Board of Directors in the best interest of the Company’s stockholders.